Financial Performance - The company's revenue for Q3 2023 was ¥244,169,068.70, a decrease of 10.56% compared to the same period last year[5]. - Net profit attributable to shareholders for Q3 2023 was ¥5,317,249.10, down 62.60% year-on-year, while net profit for the year-to-date increased by 84.17% to ¥27,203,346.16[5]. - The basic earnings per share for Q3 2023 was ¥0.0196, reflecting a decline of 62.52% compared to the previous year[5]. - Total operating revenue for the third quarter was ¥806,768,222.57, a decrease of 5.0% compared to ¥849,121,734.16 in the same period last year[30]. - Net profit for the third quarter was ¥25,837,614.83, an increase of 100.0% compared to ¥12,913,576.85 in the previous year[32]. - Earnings per share (EPS) for the quarter was ¥0.1001, compared to ¥0.0543 in the previous year, reflecting an 84.5% increase[33]. Assets and Liabilities - The total assets at the end of Q3 2023 were ¥1,953,716,677.89, showing a slight increase of 0.26% from the end of the previous year[5]. - As of September 30, 2023, total current assets amounted to 1,150,024,062.04 RMB, a slight decrease from 1,158,529,331.22 RMB at the beginning of the year[27]. - The total assets of the company as of September 30, 2023, are 1,953,716,677.89 RMB, compared to 1,948,631,068.52 RMB at the beginning of the year[28]. - The company has a total of 803,692,615.85 RMB in non-current assets as of September 30, 2023[28]. - The total liabilities as of September 30, 2023, are 437,082,769.14 RMB, down from 474,538,602.37 RMB at the beginning of the year[28]. - Total liabilities decreased to ¥496,031,401.28 from ¥516,877,589.79, indicating a reduction of 4.0%[30]. Cash Flow - The net cash flow from operating activities for the year-to-date reached ¥161,915,638.19, a significant increase of 1,329.19%[5]. - The company reported a net cash flow from operating activities of ¥161,915,638.19, a significant improvement from a negative cash flow of ¥13,172,538.75 in the same period last year[35]. - The net cash flow from investment activities was -¥62,580,376.26, a 50.96% improvement compared to the previous year, due to reduced long-term asset investments[18]. - The net cash flow from investment activities was -62,580,376.26 CNY, compared to -127,611,611.67 CNY in the previous period, indicating a reduction in cash outflow[37]. - Total cash inflow from financing activities was 3,153,607.33 CNY, while cash outflow was 12,871,230.32 CNY, resulting in a net cash flow of -9,717,622.99 CNY[37]. - The net increase in cash and cash equivalents was 92,278,954.03 CNY, contrasting with a decrease of -154,377,006.19 CNY in the previous period[37]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 15,632[20]. - The largest shareholder, Jin Liwei, holds 59.26% of the shares, totaling 161,099,964 shares[20]. - The company has not reported any shareholders participating in margin trading[22]. Operational Highlights - The company recorded a 303.51% increase in prepaid accounts, totaling ¥19,596,761.72, due to increased advance payments during the reporting period[12]. - Inventory decreased by 40.69% to ¥108,192,665.52, attributed to improved inventory management and turnover[12]. - The company experienced a 280.73% increase in lease liabilities, totaling ¥12,515,315.65, due to the addition of leased assets during the reporting period[12]. - The company reported a 109.01% increase in tax and additional fees, amounting to ¥6,646,350.41, primarily due to higher VAT payments[14]. - Research and development expenses were ¥33,236,458.10, a decrease of 12.0% from ¥37,941,884.09 in the previous year[30]. Brand and Market Performance - The company's self-owned brand revenue for the first three quarters of 2023 reached 367 million RMB, an increase of 18.97% year-on-year[23]. - Online sales of the self-owned brand grew by 10.85%, while offline sales increased by 47.74%[23]. - The company has increased its brand investment and held a global strategic launch event in August 2023[23]. Miscellaneous - The company did not undergo an audit for the third-quarter report[39]. - The report was released on October 26, 2023, by the board of directors[39].

杭州可靠护理用品股份有限公司（以下简称"公司"）于近日收到国泰君安 证券股份有限公司（以下简称"国泰君安证券"）出具的《关于更换杭州可靠护 理用品股份有限公司首次公开发行股票持续督导之保荐代表人的函》。 国泰君安证券系公司首次公开发行 A 股股票并在创业板上市的保荐人及主 承销商，原委派陈圳寅先生、唐伟先生为该项目的签字保荐代表人，负责保荐工 作及持续督导工作。 现因原保荐代表人唐伟先生工作变动，无法继续履行对公司的持续督导职责， 为保证持续督导工作的有序进行，国泰君安证券委派庞燎源先生（简历详见附件） 接替唐伟先生负责公司首次公开发行 A 股股票并在创业板上市的持续督导工作， 继续履行持续督导职责。 本次变更后，公司首次公开发行 A 股股票并在创业板上市的持续督导保荐代 表人为陈圳寅先生和庞燎源先生，持续督导期至 2024 年 12 月 31 日止。 公司董事会对原保荐代表人唐伟先生在公司首次公开发行 A 股股票并在创 业板上市项目以及持续督导期间所做出的贡献表示衷心感谢！ 证券代码：301009 证券简称：可靠股份 公告编号：2023-041 杭州可靠护理用品股份有限公司 关于变更保荐代表人的公告 本公司 ...

Financial Performance - The company reported a revenue of RMB 500 million for the first half of 2023, representing a 15% increase compared to the same period last year[18]. - The net profit attributable to shareholders reached RMB 80 million, up 20% year-on-year[18]. - The company anticipates a revenue growth forecast of 10-15% for the full year 2023[18]. - The company's revenue for the first half of 2023 was ¥562,599,153.87, a decrease of 2.35% compared to the same period last year[24]. - Net profit attributable to shareholders reached ¥21,886,097.06, an increase of 3,844.05% year-on-year[24]. - The net cash flow from operating activities was ¥99,559,382.99, a significant increase of 2,990.04% compared to the same period last year[24]. - The total comprehensive income for the first half of 2023 was CNY 24.91 million, compared to CNY 12.99 million in the same period last year, indicating a growth of 92.83%[165]. - The total operating revenue for the first half of 2023 was CNY 562,599,153.87, a decrease of 2.8% compared to CNY 576,126,971.60 in the same period of 2022[160]. - The company's operating profit improved to CNY 27.05 million, up from CNY 11.73 million in the first half of 2022, reflecting a growth of 130.61%[164]. Market Expansion and Strategy - The company plans to expand its market presence in Southeast Asia, targeting a 30% increase in market share by the end of 2024[18]. - The company is exploring strategic acquisitions to enhance its product portfolio and market reach[18]. - The company is transitioning from a manufacturing-focused model to a brand-oriented approach, enhancing its market position in adult incontinence products[37]. - The company plans to enhance its market control and competitiveness by increasing capital investment in channel expansion and innovation in product development[90]. - The company aims to enhance its competitive edge through strategic partnerships and potential acquisitions in the healthcare sector[176]. Product Development and Innovation - New product launches are expected to contribute an additional RMB 50 million in revenue for the second half of 2023[18]. - The company launched a new product, "Absorbent Treasure" active pants, designed for individuals with moderate incontinence, emphasizing a thinner and more comfortable fit[37]. - The company has developed a range of adult incontinence products, including adult diapers, pull-ups, and nursing pads, targeting the aging population in China[44]. - The company has launched a women's health care product line targeting women aged 25-40, expanding its product offerings in the health care sector[39]. - The company is actively seeking to expand its customer base globally to reduce reliance on major clients, such as JS in the Philippines, to mitigate customer concentration risks[94][95]. Research and Development - The company has invested RMB 20 million in R&D for new technologies aimed at improving product quality and sustainability[18]. - As of June 30, 2023, the company holds 264 valid patents, including 55 invention patents, showcasing its strong research and development capabilities[49]. - Research and development expenses decreased to CNY 18.81 million from CNY 20.07 million, showing a reduction of 6.3%[163]. - The company has allocated resources for research and development to innovate new products and improve existing technologies[181]. Financial Management and Investments - The total amount of raised funds is CNY 76,155.48 million, with CNY 13,938.69 million invested during the reporting period[68]. - The cumulative investment of raised funds reached CNY 48,820.74 million as of June 30, 2023[71]. - The company has not made significant changes to the measurement attributes of major assets during the reporting period[64]. - The company has not engaged in high-risk entrusted financial management activities that could lead to potential impairment[81]. - The company has not reported any overdue amounts or unrecovered funds from entrusted financial management activities, with a total of CNY 30 million in bank financial products[81]. Risk Management - The management highlighted potential risks including supply chain disruptions and increased raw material costs[3]. - The company faces operational risks due to fluctuations in raw material prices, primarily for fluff pulp, non-woven fabric, superabsorbent polymer, wood pulp, hot melt adhesive, and packaging bags, which are largely derived from petroleum products[91]. - The company has implemented risk management measures for foreign exchange derivatives, including prohibiting speculative trading and setting transaction limits approved by the board[83]. Corporate Governance and Compliance - The company has not faced any administrative penalties related to environmental issues during the reporting period[106]. - The company has not reported any non-operating fund occupation by controlling shareholders or related parties during the reporting period[110]. - The company's semi-annual financial report has not been audited[112]. - The company has not engaged in speculative derivative investments during the reporting period[84]. Shareholder Information - The company reported a 66.53% participation rate in the 2022 annual general meeting held on May 18, 2023[100]. - The company plans not to distribute cash dividends or issue bonus shares for the first half of 2023[102]. - The company has a total of 174,262,415 restricted shares at the end of the reporting period[137]. - The largest shareholder, Jin Liwei, holds 59.26% of the shares, totaling 161,099,964 shares[139]. Operational Efficiency - The cost of sales decreased by 8.28% to ¥464,068,174.15, attributed to lower material costs and reduced shipping expenses[56]. - The company has a robust procurement management system, ensuring stable supply and quality of raw materials through long-term agreements with reliable suppliers[43]. - The company has established a comprehensive quality control system certified by ISO, ensuring high product quality and operational efficiency[53].

国泰君安证券股份有限公司 关于杭州可靠护理用品股份有限公司 经中国证券监督管理委员会《关于同意杭州可靠护理用品股份有限公司首次 公开发行股票注册的批复》（证监许可〔2021〕1630 号），公司向社会公众公开发 行人民币普通股（A 股）股票 6,797.00 万股，发行价为人民币 12.54 元/股，股票 发行募集资金总额为 85,234.38 万元，扣除各项发行费用合计 9,078.90 万元，实 际募集资金净额为 76,155.48 万元。上述募集资金到位情况已经天健会计师事务 所（特殊普通合伙）验证，并由其出具《验资报告》（天健验〔2021〕294 号）。 公司对募集资金进行了专户存储，并与保荐机构、募集资金存放银行签订了《募 集资金三方监管协议》。 二、 募集资金投资项目情况 根据《公司首次公开发行股票并在创业板上市招股说明书》（以下简称"招 股说明书"）以及公司实际募集资金情况，并经公司第四届董事会第十一次会议 及第四届监事会第三次会议审议通过，公司募投项目募集资金投资额经调整后列 示如下： 单位：万元 | 项目名称 | 总投资额 | 调整后拟投入募集 | | --- | --- | --- | | ...

1、本次计提减值准备的原因 证券代码：301009 证券简称：可靠股份 公告编号：2023-040 杭州可靠护理用品股份有限公司 关于 2023 年半年度计提信用减值准备和资产减值准备 的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 杭州可靠护理用品股份有限公司（以下简称"公司"）于 2023 年 8 月 28 日召开第四届董事会第二十三次会议及第四届监事会第十二次会议审议通过了 《关于 2023 年半年度计提信用减值准备和资产减值准备的议案》，现将具体情 况公告如下： 一、本次计提减值准备情况概述 根据《企业会计准则》以及公司会计政策等相关规定，为真实、准确反映公 司财务状况、资产价值及经营成果，公司对截至 2023 年 6 月 30 日合并报表范围 内的各类资产进行了全面检查和减值测试，基于谨慎性原则，公司对可能发生减 值损失的资产计提相应减值准备。 2、本次计提减值准备的资产范围、总金额和拟计入的报告期间 经公司及子公司对截至 2023 年 6月 30 日存在可能发生减值迹象的资产进行 全面清查和资产减值测试后，计提各项减值准备共计 10,812 ...

证券代码：301009 证券简称：可靠股份 公告编号：2023-039 杭州可靠护理用品股份有限公司 关于使用闲置募集资金进行现金管理的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要提示内容： 1、投资种类：杭州可靠护理用品股份有限公司（以下简称"公司"）拟使 用闲置募集资金购买安全性高、流动性好、低风险、单项产品投资期限不超过 12 个月的理财产品，包括协定存款、结构性存款、大额存单、保本型银行理财 产品等品种，且投资产品不得进行质押，收益分配采用现金分配方式。 2、投资金额：公司拟使用额度不超过人民币 30,000 万元的闲置募集资金 进行现金管理，使用期限自公司董事会审议通过之日起 12 个月内有效。在上述 额度和期限范围内，资金可以循环滚动使用。闲置募集资金现金管理到期后将 及时归还至募集资金专户。 3、特别风险提示：本次使用闲置募集资金进行现金管理事项尚存在宏观经 济波动风险及投资收益不可预期等风险，敬请投资者注意投资风险。 公司于 2023 年 8 月 28 日召开第四届董事会第二十三次会议、第四届监事 会第十二次会议，审议通过了《关于 ...

证券代码：301009 证券简称：可靠股份 公告编号：2023-038 （二）募集资金使用和结余情况 杭州可靠护理用品股份有限公司 关于 2023 年半年度募集资金存放与实际使用情况的 专项报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 杭州可靠护理用品股份有限公司（以下简称"公司"或"本公司"）于 2023 年 8 月 28 日召开了第四届董事会第二十三次会议、第四届监事会第十二 次会议，审议通过了《关于 2023 年半年度募集资金存放与实际使用情况的专项 报告的议案》。 根据《上市公司监管指引第 2 号——上市公司募集资金管理和使用的监管 要求》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规 范运作》等有关规定，将公司截至 2023 年 6 月 30 日的募集资金存放与实际使 用情况报告如下： 一、募集资金基本情况 （一）实际募集资金金额和资金到账时间 根据中国证券监督管理委员会《关于同意杭州可靠护理用品股份有限公司首 次发行股票注册的批复》（证监许可〔2021〕1630 号），公司由主承销商国泰君 安证券股份有限公司（以下简称" ...

根据《上市公司监管指引第 8 号——上市公司资金往来、对外担保的监管要 求》等规定和要求，作为公司的独立董事，我们对公司 2023 年半年度控股股东 及其关联方占用公司资金情况、公司对外担保情况进行了认真的核查，现发表如 下专项说明和独立意见： 1、关联方资金往来情况 截至 2023 年 6 月 30 日，公司与控股股东及其他关联方的资金往来均为正常 的经营性资金往来，不存在控股股东及其他关联方违规占用公司资金的情况，也 不存在以前年度发生并累计至报告期末的控股股东及关联方违规占用资金情况。 杭州可靠护理用品股份有限公司 独立董事关于第四届董事会第二十三次会议 相关事项的独立意见 根据《中华人民共和国公司法》《上市公司独立董事规则》《深圳证券交易所 上市公司自律监管指引第 2 号——创业板上市公司规范运作》等有关法律法规、 规范性法律文件以及《杭州可靠护理用品股份有限公司章程》的有关规定，我们 作为杭州可靠护理用品股份有限公司（以下简称"公司"）的独立董事，本着审 慎、负责的态度，基于独立判断立场，对公司第四届董事会第二十三次会议相关 事项发表独立意见如下： 一、关于公司 2023 年半年度控股股东及其他关联 ...

证券代码：301009 证券简称：可靠股份 公告编号：2023-035 杭州可靠护理用品股份有限公司 第四届董事会第二十三次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 经与会董事审议，一致认为公司《2023 年半年度报告》全文及其摘要内容 符合相关法律法规及《公司章程》的有关规定，报告内容真实、准确、完整， 不存在任何虚假记载、误导性陈述或者重大遗漏。 表决结果：7 票同意，0 票反对，0 票弃权。 具体内容详见公司披露于巨潮资讯网（http://www.cninfo.com.cn)的 《2023 年半年度报告》全文及《2023 年半年度报告摘要》（公告编号：2023- 037）。 一、董事会会议召开情况 杭州可靠护理用品股份有限公司（以下简称"公司"）第四届董事会第二 十三次会议于 2023 年 8 月 28 日（星期一）在浙江省杭州市余杭区向往街 1118 号公司会议室以现场结合通讯的方式召开。会议通知已于 2023 年 8 月 18 日通 过邮件等方式送达各位董事。本次会议应出席董事 7 人，实际出席董事 7 人， 其中董事吴志伟先生、 ...

| 保荐机构名称：国泰君安证券股份有限公司 | 被保荐公司简称：可靠股份 | | --- | --- | | 保荐代表人姓名：陈圳寅 | 联系电话：010-83939236 | | 保荐代表人姓名：唐 伟 | 联系电话：010-83939235 | 一、保荐工作概述 | 项目 | 工作内容 | | --- | --- | | 1、公司信息披露审阅情况 | | | （1）是否及时审阅公司信息披露文件 | 是 | | （2）未及时审阅公司信息披露文件的次数 | 不适用 | | 2、督导公司建立健全并有效执行规章制度的情况 | | | （1）是否督导公司建立健全规章制度（包括但不限于防止 关联方占用公司资源的制度、募集资金管理制度、内控制 | 是 | | 度、内部审计制度、关联交易制度） | | | （2）公司是否有效执行相关规章制度 | 是 | | 3、募集资金监督情况 | | | （1）查询公司募集资金专户次数 | 每月 1 次 | | （2）公司募集资金项目进展是否与信息披露文件一致 | 是 | | 4、公司治理督导情况 | | | （1）列席公司股东大会次数 | 未列席，已阅会议文件 | | （2）列席公司 ...